Estrogen
Estrogens are a group of steroid hormones that play a crucial role in the reproductive and sexual development, primarily in females. While often associated with female physiology, estrogens are present and functional in both sexes, contributing to a wide array of bodily processes. The ability to accurately determine estrogen levels in the body, known as estrogen , is a fundamental diagnostic tool in medicine and research.
Biological Basis
Section titled “Biological Basis”Estrogens are primarily produced in the ovaries, adrenal glands, and fat tissue, with the placenta being a significant source during pregnancy. The three major naturally occurring estrogens in humans are estradiol (E2), estrone (E1), and estriol (E3). Estradiol is the most potent and prevalent estrogen during a woman’s reproductive years. Estrone is the primary estrogen after menopause, and estriol is the main estrogen during pregnancy. These hormones exert their effects by binding to estrogen receptors located in various tissues throughout the body, influencing gene expression and cellular function. Estrogens are vital for the development of female secondary sexual characteristics, regulation of the menstrual cycle, maintenance of bone density, cardiovascular health, and cognitive function.
Clinical Relevance
Section titled “Clinical Relevance”Measuring estrogen levels is clinically relevant for diagnosing and managing various conditions. In reproductive health, it helps assess ovarian function, track ovulation in fertility treatments, and diagnose conditions like polycystic ovary syndrome (PCOS) or primary ovarian insufficiency. Estrogen levels are also monitored during menopause to understand hormonal changes and guide hormone replacement therapy (HRT). Furthermore, estrogen is critical in oncology, particularly for hormone-sensitive cancers such as breast cancer and prostate cancer, where estrogen can fuel tumor growth. Monitoring estrogen levels can help determine prognosis and guide treatment strategies. It is also used in evaluating bone health, as estrogen deficiency is a known risk factor for osteoporosis.
Social Importance
Section titled “Social Importance”The understanding and of estrogen have significant social implications, particularly in areas concerning women’s health, aging, and gender-affirming care. Accurate estrogen assessment empowers individuals and healthcare providers to make informed decisions about reproductive health, family planning, and managing symptoms associated with hormonal fluctuations throughout life. It contributes to broader public health discussions on aging, bone health, and cancer prevention, highlighting the widespread impact of these hormones on well-being and quality of life. The accessibility and interpretation of estrogen measurements are key to personalized medicine and optimizing health outcomes across diverse populations.
Methodological and Statistical Considerations
Section titled “Methodological and Statistical Considerations”Studies investigating estrogen, while leveraging large-scale genetic datasets, inherently face limitations concerning statistical power and the reproducibility of findings. Although some analyses draw upon cohorts of hundreds of thousands of individuals, such as the 206,927 participants used for estradiol instrument derivation, the varying sample sizes across different traits or analyses can impact the ability to robustly detect all relevant genetic associations, particularly those with subtle effects . Changes inCYP19A1activity can influence the local and systemic availability of estrogen, thereby affecting the risk of hormone-sensitive conditions such as breast cancer and uterine leiomyoma, which are significantly influenced by estrogen exposure . Similarly, the long non-coding RNAMIR4713HGcan regulate gene expression, and its variants may indirectly affect hormone pathways by altering the expression of genes involved in cellular growth and differentiation.
Several variants within the SLC22A family of solute carrier genes, including rs184061227 near TUBAP7 - SLC22A24, rs59922153 in SLC22A10, rs117070489 in SLC22A25, and rs511686 in SLC22A9, are implicated in diverse physiological processes. These genes encode organic cation transporters (OCTs) and organic anion transporters (OATs), which are vital for the transport of a wide array of endogenous compounds, including hormones, neurotransmitters, and xenobiotics, as well as many drugs, across cell membranes. Variations in these transporters can alter the uptake, distribution, metabolism, and excretion of substances, potentially influencing the effective concentration of estrogens or other steroid hormones in target tissues.[1]Such changes can contribute to altered hormone signaling, impacting the risk for conditions like uterine leiomyoma and various cancers, which are often sensitive to hormonal environments.[2] Other notable variants include rs34670419 in ZKSCAN5, a zinc finger protein involved in transcriptional regulation, and rs56400819 in GML, which may play a role in cell growth and differentiation. ZKSCAN5variants could affect the expression of genes critical for cellular responses to estrogen, whileGMLvariations might influence the proliferation of hormone-sensitive cells. Additionally,rs78765146 in SYT7 (Synaptotagmin 7), a gene involved in calcium-dependent membrane fusion and exocytosis, could impact cellular communication and signaling pathways that are often modulated by hormones.[1] Variants like rs112072149 near SDHAF2 - SAXO4 and rs72918068 in DAGLA (Diacylglycerol lipase alpha) also contribute to the complex genetic landscape affecting health. SDHAF2is involved in mitochondrial function, which is influenced by estrogen, whileDAGLAis critical for endocannabinoid synthesis, a system known to interact with steroid hormones in reproductive physiology and disease development.[3]The cumulative effect of these genetic variations can influence an individual’s overall hormonal balance and susceptibility to a range of hormone-related disorders.
Definition and Biological Role of Estrogen
Section titled “Definition and Biological Role of Estrogen”Estrogen refers to a group of steroid hormones vital for the development and maintenance of female reproductive tissues, as well as influencing various other physiological processes. Specifically, estradiol is a potent form of estrogen, playing a crucial role in regulating cellular proliferation.[4]This regulatory function is particularly significant in the endometrium, the lining of the uterus, where estrogen modulates growth and development throughout the menstrual cycle.[5]Understanding estrogen’s precise definition and its conceptual framework is fundamental to comprehending its impact on health and disease.
The biological actions of estrogen are mediated through specific “estradiol receptors” located within target cells. The presence of these cytoplasmic receptors has been identified in various endometrial states, including normal, hyperplastic, and carcinomatous tissues.[6]This highlights estradiol’s direct influence on endometrial cell activity and its critical involvement in both physiological processes and pathological conditions. The interplay between estrogen and other hormones, such as progestin, further defines the complex endocrine environment governing cellular proliferation within the endometrium.[4]
Operational Considerations for Assessing Estrogen Levels
Section titled “Operational Considerations for Assessing Estrogen Levels”The assessment of estrogen levels in research and clinical settings requires careful consideration of numerous physiological and demographic factors to establish robust operational definitions. For endocrine-related traits, including hormones that regulate estrogen production like Luteinizing Hormone (LH) and Follicle Stimulating Hormone (FSH), measurements are commonly adjusted for variables such as age, sex, body mass index (BMI), smoking status, and menopausal status.[7]These adjustments are essential to account for natural variations and potential confounders that can influence hormone concentrations.
Clinical and research criteria for interpreting estrogen levels often involve specific sub-populations, necessitating precise operational definitions. For instance, studies might focus on men or post-menopausal women who are not undergoing hormone replacement treatment or using oral contraceptive pills, to isolate endogenous hormone effects.[7]Such careful stratification and multivariable adjustment ensure that measured values are interpreted within an appropriate biological context, thereby enhancing the accuracy and clinical utility of estrogen assessment.
Estrogen’s Role in Endometrial Health and Disease Classification
Section titled “Estrogen’s Role in Endometrial Health and Disease Classification”Estrogen is intrinsically linked to various classification systems for gynecological conditions, particularly those affecting the endometrium. Its influence on cellular proliferation positions it as a key factor in the development and classification of endometrial hyperplasia and endometrial cancer.[8]The sustained or unbalanced activity of estrogen can promote abnormal cell growth, contributing to the progression from normal tissue to hyperplastic states and ultimately to carcinoma.
The diagnostic terminology and criteria related to estrogen involve the evaluation of biomarkers like “cytoplasmic progesterone and estradiol receptors” in endometrial tissues. The presence and characteristics of these receptors serve as crucial diagnostic indicators, providing insight into the hormonal responsiveness of the tissue.[6]This information is vital for disease classification, severity gradation, and guiding therapeutic strategies, as it helps determine whether a condition is hormone-sensitive and thus responsive to anti-estrogen or progestin-based treatments.
Estrogen Synthesis, Signaling, and Metabolism
Section titled “Estrogen Synthesis, Signaling, and Metabolism”Estrogens, primarily estradiol, are steroid hormones vital for a multitude of biological processes, exerting their effects by interacting with specific estrogen receptors:Estrogen receptor alpha (ERα) and Estrogen receptor beta (ERβ). These critical biomolecules, which can associate with chaperone proteins like Hsp70, mediate estrogen’s cellular functions by binding the hormone and subsequently modulating gene expression.[9]The precise balance of estrogen signaling pathways is crucial, as the presence and distribution ofERα and ERβin tissues, such as uterine fibroids, dictate the cellular responsiveness to estrogen.[9]The body meticulously regulates estrogen levels through intricate synthesis and metabolic processes. Enzymes, particularly those encoded by genes likeCYP19A1, are central to estrogen metabolism, and genetic variations within these genes can influence an individual’s estrogen profile and susceptibility to certain conditions.[10]Beyond endogenous production, external factors such as moderate alcoholic beverage consumption can also impact serum estradiol levels in postmenopausal women, illustrating the complex interplay of genetic, environmental, and metabolic factors that determine estrogen availability and its systemic consequences.[11]
Genetic and Epigenetic Regulation of Estrogen Responsiveness
Section titled “Genetic and Epigenetic Regulation of Estrogen Responsiveness”Genetic mechanisms profoundly shape estrogen’s biological impact, governing both its production and the cellular response to it through complex regulatory networks. The proper functioning of genes, such as thefollicle-stimulating hormone beta-subunitgene, is essential for normal reproductive development, with mutations potentially leading to conditions like delayed puberty and hypogonadism.[12]Furthermore, the broader estrogen receptor signaling pathways are fundamental during vertebrate development, highlighting the integral role of genetic programming in orchestrating the extensive developmental effects of these hormones.[13]The specific gene expression patterns of estrogen receptors and other related components are crucial regulatory elements that determine tissue sensitivity and overall physiological outcomes.
Beyond direct gene function, the responsiveness to estrogen is fine-tuned by regulatory networks involving transcription factors and epigenetic modifications. For example, altered expression patterns ofERα and ERβin pathological conditions like uterine fibroids can lead to a modified cellular response to estrogen, contributing to disease progression.[9]This intricate genetic and epigenetic control dictates how various tissues perceive and react to circulating estrogen, influencing everything from the normal proliferation kinetics of the human endometrium during the menstrual cycle to the growth and development of hormone-sensitive tumors.[5]
Estrogen’s Role in Tissue Development and Systemic Homeostasis
Section titled “Estrogen’s Role in Tissue Development and Systemic Homeostasis”Estrogen is a pivotal hormone in orchestrating developmental processes and maintaining systemic homeostasis across a diverse array of tissues and organs. During puberty, elevated estrogen levels initiate the development of secondary sexual characteristics and drive reproductive maturation.[14]Within the reproductive system, hormones like follicle-stimulating hormone (FSH) collaborate with estrogen to accelerate oocyte development, ensuring proper ovarian function.[15]Estrogen also significantly impacts tissue interactions beyond the reproductive tract, playing a critical role in bone health by influencing bone mineral density through its interaction with estrogen and androgen receptors.[16]Furthermore, estrogen contributes to homeostatic regulation in various physiological systems throughout life. It influences musculoskeletal performance and may affect injury risk, particularly in peri- and post-menopausal women where hormonal fluctuations are common.[17]However, the systemic consequences of estrogen are complex; while often associated with beneficial effects, estrogen therapy has also been linked to changes in coronary-artery calcification, underscoring the nuanced and multifaceted impact of this hormone on cardiovascular health.[18]This dynamic interplay between estrogen and diverse tissues highlights its broad significance in maintaining physiological balance.
Estrogen in Pathophysiological Processes
Section titled “Estrogen in Pathophysiological Processes”Dysregulation of estrogen signaling and metabolism is a central factor in the pathophysiology of several diseases, primarily affecting hormone-sensitive tissues. Uterine leiomyomata, commonly known as fibroids, are highly responsive to estrogen, with altered expression ofERα and ERβ contributing significantly to their growth.[9]The development of these benign tumors is also influenced by other factors such as angiogenic factors, hypertension, and even a genetic predisposition to gain muscle mass, indicating a complex interplay of hormonal, genetic, and environmental elements.[19]Similarly, endometriosis, characterized by the presence of endometrial tissue outside the uterus, shares common genetic origins with uterine leiomyomata and is also profoundly influenced by estrogen.[20]Estrogen’s role in cancer development is well-established, particularly in hormone-sensitive malignancies. The presence of unopposed estrogen, where progesterone levels are insufficient to counteract estrogen’s proliferative effects, is a significant risk factor for endometrial cancer, directly affecting endometrial mitotic rates and increasing cancer risk.[21]Obesity, which can lead to increased peripheral estrogen production, has been identified as a causal risk factor for uterine endometrial cancer and is also recognized as an avoidable cause of cancer in Europe.[3]In breast cancer, circulating levels of other hormones like prolactin, insulin, and c-peptide, which often interact with or are modulated by estrogen pathways, are associated with risk, further emphasizing estrogen’s pervasive influence on cellular proliferation and disease progression.[22]
Endocrine Regulation and Metabolic-Cardiovascular Risk
Section titled “Endocrine Regulation and Metabolic-Cardiovascular Risk”The clinical utility of assessing endocrine-related traits, such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH), is paramount for understanding the intricate hormonal regulation that underpins metabolic and cardiovascular health. These hormones are pivotal in regulating gonadal function, thereby indirectly reflecting the broader endocrine milieu, including estrogenic activity.[7]Comprehensive studies often evaluate these markers in conjunction with a wide array of metabolic risk factors, including age, body mass index, diabetes mellitus, impaired fasting glucose, blood pressure metrics, hypertension treatment, and lipid profiles, to identify individuals at elevated risk for chronic conditions. This integrated approach supports personalized medicine by recognizing the profound interplay between endocrine status and systemic health.
Monitoring these endocrine indicators offers significant prognostic value, aiding in the prediction of disease progression and long-term implications, particularly in conditions where hormonal balance is a key determinant. By stratifying risk based on these endocrine traits, adjusted for crucial confounders like smoking and alcohol intake, clinicians can develop targeted prevention strategies. This detailed assessment, especially in populations like post-menopausal women not on hormone therapy, provides crucial insights for treatment selection by illuminating the role of the endocrine system in overall patient well-being and its associations with prevalent cardiovascular disease.[7]
Reproductive Endocrine Assessment and Age-Related Changes
Section titled “Reproductive Endocrine Assessment and Age-Related Changes”The of key regulatory hormones like LH and FSHoffers essential diagnostic utility in evaluating reproductive endocrine function, particularly during significant physiological transitions such as natural menopause. These assessments provide crucial insights into the hormonal environment of individuals, especially in post-menopausal women not using hormone replacement therapy or oral contraceptives, where changes in these hormones reflect altered estrogen production.[7] Understanding these dynamics is vital for comprehensive patient care, allowing for the identification of related conditions and potential complications linked to age-related hormonal shifts, thereby informing long-term health management strategies.
This approach facilitates personalized monitoring strategies and risk assessment in individuals undergoing natural menopause. By considering the profiles of LH and FSHalongside various physiological and lifestyle factors, clinicians can better understand overlapping phenotypes and syndromic presentations where endocrine status plays a significant role. This comprehensive risk stratification enables healthcare providers to offer precise guidance on preventive measures and therapeutic interventions, ultimately aiming to optimize patient outcomes across the lifespan.[7]
Key Variants
Section titled “Key Variants”| RS ID | Gene | Related Traits |
|---|---|---|
| rs2414098 | MIR4713HG, CYP19A1 | endometrial endometrioid carcinoma endometrial carcinoma bone tissue density BMI-adjusted hip circumference alkaline phosphatase |
| rs34670419 | ZKSCAN5 | bone tissue density hormone , progesterone amount hormone , dehydroepiandrosterone sulphate hormone , testosterone femoral neck bone mineral density |
| rs56400819 | GML | estrogen |
| rs184061227 | TUBAP7 - SLC22A24 | estrogen |
| rs59922153 | SLC22A10 | estrogen eicosanoids |
| rs117070489 | SLC22A25 | estrogen |
| rs78765146 | SYT7 | estrogen |
| rs511686 | SLC22A9 | estrogen gut microbiome , allergen exposure |
| rs112072149 | SDHAF2 - SAXO4 | estrogen |
| rs72918068 | DAGLA | estrogen docosahexaenoic acid to total fatty acids percentage docosahexaenoic acid |
Frequently Asked Questions About Estrogen
Section titled “Frequently Asked Questions About Estrogen”These questions address the most important and specific aspects of estrogen based on current genetic research.
1. Why do some women have an easy menopause and I don’t?
Section titled “1. Why do some women have an easy menopause and I don’t?”Individual responses to hormonal changes during menopause can vary greatly. Your unique genetic makeup plays a role in how your body produces and processes estrogens like estrone (E1), which is primary after menopause, and how your tissues respond to these changes. Environmental factors like lifestyle also contribute, making everyone’s experience different.
2. Can my diet actually affect my estrogen levels?
Section titled “2. Can my diet actually affect my estrogen levels?”Yes, absolutely. Your diet is a significant environmental factor that can interact with your genetic predispositions to influence your estrogen levels. While genes set a baseline, what you eat can affect hormone production, metabolism, and even the tissues where estrogens are stored, contributing to your overall hormonal balance.
3. My mom had breast cancer; does that mean my estrogen puts me at high risk?
Section titled “3. My mom had breast cancer; does that mean my estrogen puts me at high risk?”Having a family history of breast cancer suggests a potential genetic predisposition, and estrogen can indeed fuel the growth of certain types of breast cancer. While your genetics play a role in how your body produces and uses estrogen, it’s a complex interaction. Regular monitoring and discussions with your doctor can help assess your personal risk.
4. I’m not European; does my background change how my body handles estrogen?
Section titled “4. I’m not European; does my background change how my body handles estrogen?”Yes, your ancestral background can absolutely influence how your body handles estrogen. Much of the research on genetic factors affecting estrogen levels has focused on people of European descent. Genetic differences across diverse populations mean that findings from one group may not fully apply to others, impacting how your body produces or responds to these hormones.
5. What would an estrogen test tell me if I’m trying to get pregnant?
Section titled “5. What would an estrogen test tell me if I’m trying to get pregnant?”An estrogen test is very helpful for fertility! It can tell you about your ovarian function, helping doctors track when you’re ovulating. Measuring estradiol (E2), the main estrogen during reproductive years, can also help diagnose conditions like PCOS or primary ovarian insufficiency, guiding your fertility treatment plan.
6. Does being really stressed out mess with my hormones?
Section titled “6. Does being really stressed out mess with my hormones?”Yes, high stress can certainly influence your hormone balance, including estrogens. While genetic studies focus on inherited variations, environmental factors like chronic stress are known to impact your body’s overall physiological processes, which can in turn affect the production and regulation of hormones like estrogen.
7. My friend and I are the same age, but her bones are stronger. Why?
Section titled “7. My friend and I are the same age, but her bones are stronger. Why?”Even if you’re the same age, individual genetic differences play a significant role in bone density and how your body uses estrogen, which is vital for bone health. Your unique genetic makeup, combined with lifestyle factors like diet and exercise, can influence your estrogen levels and how effectively they protect your bones.
8. My doctor wants to measure my estrogen before HRT, but isn’t it obvious it’s low?
Section titled “8. My doctor wants to measure my estrogen before HRT, but isn’t it obvious it’s low?”While it might seem obvious, measuring your specific estrogen levels before Hormone Replacement Therapy (HRT) is crucial for personalized care. Different types of estrogen (like estrone, E1, which is primary after menopause) might be measured, and knowing your exact levels helps your doctor tailor the HRT dose and type specifically for you, optimizing benefits and minimizing risks.
9. My husband thinks estrogen is just for women. Is that true?
Section titled “9. My husband thinks estrogen is just for women. Is that true?”That’s a common misconception! Estrogens are definitely present and functional in both men and women. In men, they play roles in bone health, cardiovascular health, and even cognitive function. For instance, estrogen levels are monitored in conditions like prostate cancer, showing their importance in male physiology too.
10. Can exercising a lot change my estrogen levels?
Section titled “10. Can exercising a lot change my estrogen levels?”Yes, your exercise habits are a lifestyle factor that can influence your estrogen levels. While your genetics set a foundation, intense or prolonged exercise, or even regular moderate activity, can affect hormone production, metabolism, and overall body fat, which is also a source of estrogen. It’s part of the complex interplay between your body and environment.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
Section titled “References”[1] Wu X, et al. “A comprehensive genome-wide cross-trait analysis of sexual factors and uterine leiomyoma.” PLoS Genet. PMID: 38701081.
[2] Rafnar T, et al. “Variants associating with uterine leiomyoma highlight genetic background shared by various cancers and hormone-related traits.” Nat Commun. PMID: 30194396.
[3] Masuda T, et al. “GWAS of five gynecologic diseases and cross-trait analysis in Japanese.” Eur J Hum Genet. PMID: 31488892.
[4] Clarke, C. L. & Sutherland, R. L. “Progestin regulation of cellular proliferation.” Endocr Rev, vol. 11, 1990, pp. 266–301.
[5] Ferenczy, A. et al. “Proliferation kinetics of human endometrium during the normal menstrual cycle.” Am J Obstet Gynecol, vol. 133, 1979, pp. 859–867.
[6] Ehrlich, C. E. et al. “Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications.”Am J Obstet Gynecol, vol. 141, 1981, pp. 539–546.
[7] Hwang, S. J. “A genome-wide association for kidney function and endocrine-related traits in the NHLBI’s Framingham Heart Study.” BMC Medical Genetics, 2007.
[8] De Vivo, I. “Genome-wide association study of endometrial cancer in E2C2.”Human Genetics, vol. 132, no. 10, 2013, pp. 1131-42.
[9] Bakas, P. et al. “Estrogen receptor α and β in uterine fibroids: a basis for altered estrogen responsiveness.”Fertil. Steril., vol. 90, 2008, pp. 1878–1885.
[10] Setiawan VW, et al. “Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium.” Cancer Epidemiol Biomarkers Prev. 2009; 18:242–7.
[11] Gavaler, J. S., & Van Thiel, D. H. “The association between moderate alcoholic beverage consumption and serum estradiol and testosterone levels in normal postmenopausal women: relationship to the literature.”Alcohol Clin Exp Res, vol. 16, no. 1, 1992, pp. 87–92.
[12] Layman, L. C. et al. “Delayed puberty and hypogonadism caused by mutations in the follicle-stimulating hormone beta-subunit gene.”N. Engl. J. Med., vol. 337, 1997, pp. 607–611.
[13] Bondesson, M. et al. “Estrogen receptor signaling during vertebrate development.”Biochim Biophys. Acta, vol. 1849, 2015, pp. 142–151.
[14] Wood, C. L. et al. “Puberty: normal physiology (brief overview).” Best. Pract. Res. Clin. Endocrinol. Metab., vol. 33, 2019, p. 101265.
[15] Demeestere, I. et al. “Follicle-stimulating hormone accelerates mouse oocyte development in vivo.”Biol. Reprod., vol. 87, 2012, pp. 1–11.
[16] Manolagas, S. C. et al. “The role of estrogen and androgen receptors in bone health and disease.”Nat Rev Endocrinol., vol. 9, 2013, pp. 699–712.
[17] Chidi-Ogbolu, N. & Baar, K. “Effect of estrogen on musculoskeletal performance and injury risk.”Front. Physiol., vol. 9, 2018, p. 1834.
[18] Manson, J. E. et al. “Estrogen therapy and coronary-artery calcification.”N Engl J Med, vol. 356, 2007, pp. 2591–2602.
[19] Tal, R. & Segars, J. H. “The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy.” Hum. Reprod. Update, vol. 20, 2014, pp. 194–216.
[20] Gallagher, C. S. et al. “Genome-wide association and epidemiological analyses reveal common genetic origins between uterine leiomyomata and endometriosis.”Nat Commun, vol. 10, 2019, p. 4843.
[21] Herrinton, L. J. & Weiss, N. S. “Postmenopausal unopposed estrogens. Characteristics of use in relation to the risk of endometrial carcinoma.”Ann Epidemiol, vol. 3, 1993, pp. 308–318.
[22] Tworoger, S. S. et al. “A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.”J Clin Oncol, vol. 25, 2007, pp. 1482–1498.